Q4 2019 Alembic Pharmaceuticals Ltd Earnings Call Transcript
And welcome to the Alembic Pharmaceuticals Limited conference call to discuss company's Q4 FY '19 annual financial results. From the management, we have with us today, Mr. Pranav Amin, Managing Director; Mr. R.K. Baheti, Director of Finance and CFO; Mr. Mitanshu Shah, Head of Finance; Mr. Jesal Shah, Head of Strategy; and Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti, Director of Finance and CFO. Thank you, and over to you, sir.
Thank you very much. Good afternoon, everyone. Thank you, once again, for joining the fourth quarter annual results conference call. I'm sure most of you have seen our results by now. I will -- let me briefly take you through the numbers for the quarter and year ended 31st March 2019.
During the quarter, total revenue grew by 9% to INR 927 crores; EBITDA, INR 174 crores is 19% of sales
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
